🇺🇸 FDA
Pipeline program

glargine + exenatide

ESR-14-10352

Approved small_molecule completed

Quick answer

glargine + exenatide for Type 2 Diabetes Mellitus is a Approved program (small_molecule) at Hong Kong Baptist University with 1 ClinicalTrials.gov record(s).

Program details

Company
Hong Kong Baptist University
Indication
Type 2 Diabetes Mellitus
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials